SDG 3Care continuity and patient safety indicators.
IMPACT EVIDENCE
Impact evidence from the field
Our pilot is actively running. These are early observations, not verified outcomes. Independent M&E evaluation is underway so public-health, donor, and investor audiences can see what is measured and what remains unproven.
EVIDENCE ALIGNMENT
Measuring the system, not just the software
Our impact work connects SDG-aligned goals to practical indicators: service continuity, procurement visibility, data governance, and partnership readiness for scale.
SDG 3Care continuity and patient safety indicators.
SDG 9Infrastructure resilience and interoperability.
SDG 17Evaluation partners and institutional learning.
PILOT OBSERVATION CARD
Manicaland District Hospital, Zimbabwe
Context: District hospital environment serving high-volume patient flows in a region where facilities can face power instability, low-bandwidth connectivity, and manual fallback processes.
What was deployed: Administration workflows, queue visibility, offline-first records continuity, and procurement monitoring modules from the SelNexa Health Platform.
What was observed: Facility staff highlighted the value of keeping intake and record workflows available during outages, reducing the need to restart work when connectivity returns, and making medicine visibility easier to discuss across teams.
Evidence status: These are qualitative pilot observations. They are not yet verified outcomes and should not be used as final impact claims.
M&E FRAMEWORK
What is being measured
Operational continuity
Offline workflow availability, sync replay success, outage recovery time, and paper fallback frequency as evidence of resilient service delivery.
Administrative efficiency
Registration time, queue handoff speed, documentation completeness, and staff time spent on duplicated work.
Procurement visibility
Stock-out alerts, expiry risk, emergency reorder frequency, and facility-level medicine visibility.
Patient safety and governance
Audit trail completeness, access-control events, consent handling, and incident reporting readiness under responsible health technology standards.
Evaluation timeline
Baseline and pilot monitoring are underway. First independent M&E results are expected in Q3 2026, subject to facility approval and data quality review.
Follow our impact updates
Quarterly notes on pilot milestones, evaluation progress, and field lessons.
No spam. Unsubscribe anytime.
Want to evaluate your own facility scenario?
Book a platform walkthrough and we will map deployment options to your current workflow constraints.